Message from the Chairman

I believe working in healthcare carries a responsibility unlike that of almost any other industry.

Because ultimately, the decisions we make, the partnerships we build, and the treatments we help make accessible across borders are not reflected merely in numbers on a balance sheet.

They can affect a human life.

Science and medicine are advancing at an extraordinary pace. Treatments are being developed today for diseases that, not long ago, had few or sometimes no meaningful therapeutic options.

Yet the existence of a treatment somewhere in the world does not necessarily mean that every patient who needs it can access it.

Regulatory pathways, reimbursement systems, supply chains and commercial priorities can leave an effective treatment thousands of miles away from the patient waiting for it.

This is the idea that inspired Orphion Pharma: to shorten that distance.

We believe the true value of a medicine is realized not simply when it is discovered, developed or approved, but when it reaches the patient who needs it.

That is why we focus particularly on serious and rare diseases and areas of significant unmet medical need, working alongside innovative pharmaceutical and biotechnology companies, physicians, healthcare authorities and other stakeholders across the patient-access ecosystem.

Our ambition goes beyond supplying medicines.

We aim to build a trusted, sustainable and responsible bridge between medical innovation, wherever it originates, and patients who need access to it.

This philosophy also defines the responsibility we assume toward our partners.

When a company entrusts us with one of its therapies, we do not see merely a commercial product. We recognize the years of scientific research behind it, the people who dedicated themselves to developing it, the investment required to bring it forward and, most importantly, the patients who may be waiting for it.

For that reason, we believe in long-term partnerships built on transparency, scientific integrity, trust and ethical responsibility.

Our journey began in Türkiye and is increasingly reaching beyond its borders. Wherever that journey takes us, however, our compass will remain the same:

To be present where the need exists.
To shorten the distance between scientific innovation and patient access.
And never to forget that behind everything we do, there is a human life.

We know that our journey is only beginning.

Our ambition is not simply to build a growing pharmaceutical company, but to build a healthcare company that is trusted, takes responsibility and acts when and where patients need it.

Because ultimately, we believe success should not be measured solely by how much a company grows, but by how many lives it helps bring closer to better treatment.

Fevzi AydınChairman & Managing PartnerOrphion Pharma